Vimta Labs

Vimta Labs EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Vimta Labs (VIMTALABS.NS) as of Oct 21, 2026 is 993.00 M INR. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 1.25 B INR — a change of -20.57% (lower).

EBITDA

993.00 MINR

YoY

-20.57%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Vimta Labs is 2026 993.00 M INR. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Vimta Labs was 2025 1.25 B INR. It decreases by -20.57% lower compared to the previous year.

The Vimta Labs EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2019
653.98 M INR
Jan 1, 2020
345.93 M INR
Jan 1, 2021
591.58 M INR
Jan 1, 2022
802.74 M INR
Jan 1, 2023
1.00 B INR
Jan 1, 2024
971.70 M INR
Jan 1, 2025
1.25 B INR
Jan 1, 2026
993.00 M INR
The Vimta Labs EBITDA history
YEAREBITDAYoY
993.00 MINR-20.57%
1.25 BINR+28.65%
971.70 MINR-3.21%
1.00 BINR+25.07%
802.74 MINR+35.69%
591.58 MINR+71.01%
345.93 MINR-47.10%
653.98 MINR+33.12%
491.27 MINR+68.78%
291.07 MINR+45.46%
200.10 MINR+0.22%
199.66 MINR-26.01%
269.84 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Vimta Labs Stock analysis

What does Vimta Labs do? Vimta Labs Ltd. provides contract research and testing services across multiple industries including biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device, power, cement, oil and gas, ores and minerals, and infrastructure. The company serves biopharmaceutical firms, medical device companies, agrochemical and specialty chemical firms, food manufacturers, processors, farmers, retailers, hospitals, and government organizations. Its services include drug discovery, development, and life cycle management support; preclinical research for medical devices; contract research for agrochemical and specialty chemicals; food testing and analytical development; clinical diagnostics for patients and hospitals; and environmental regulatory services like impact assessments and post-project monitoring for power and infrastructure sectors. The primary buyers of Vimta Labs' services are biopharmaceutical companies requiring drug development support, medical device manufacturers needing preclinical testing, agrochemical firms seeking contract research, food industry stakeholders such as manufacturers and retailers, healthcare providers including hospitals, and government entities requiring environmental assessments. These segments represent the core revenue streams for the company through its specialized testing and research offerings. Vimta Labs generates revenue by delivering tailored research and testing solutions to industry-specific clients across diverse sectors. The company’s service portfolio targets key industries where regulatory compliance and product safety are critical, ensuring consistent demand for its analytical and diagnostic services. By maintaining a broad service range, Vimta Labs secures contracts with multiple industry participants, including government organizations, to sustain its business model. Vimta Labs is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vimta Labs stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Vimta Labs is 993.00 M INR in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Vimta Labs changed from 1.25 B INR to 993.00 M INR, representing a -20.57% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Vimta Labs since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Vimta Labs historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Vimta Labs

All Key Metrics — Vimta Labs